[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100310149":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":28,"responsibleParty":58,"collaborators":60,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":27,"enrollmentInfo":72,"targetDuration":27,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":83,"whyStopped":27,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Capsaicin","EXPERIMENTAL","Cancer patients presenting neuropathic pain secondary to their anti cancer treatments will receive patch of capsaicin (qutenza) on the painful zones..",[13],"Drug: Qutenza",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Qutenza","Patients suffering from neuropathic pain will receive patch of capsaicin (qutenza) on the painful zones. Three months after the first application, patients will be allowed to receive another patch if necessary. They will be able to receive one every three months. They will be followed in the study during one year after the first patch application.",[9],[21],"8% capsaicin patch",[23],{"name":24,"affiliation":25,"role":26},"Stéphanie Morisson, MD","Institut de Cancérologie Lucien Neuwirth","PRINCIPAL_INVESTIGATOR",null,[29,41,50],{"facility":30,"status":27,"city":31,"state":27,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":27},"Centre Jean Perrin","Clermont-Ferrand","63000","France","FR",{"type":36,"coordinates":37},"Point",[38,39],3.08682,45.77969,{"lat":39,"lon":38},{"facility":42,"status":27,"city":43,"state":27,"zip":44,"country":33,"countryCode":34,"cosmosGeoPoint":45,"geoPoint":49,"contacts":27},"Centre Hospitalier Emile Roux","Le Puy-en-Velay","43000",{"type":36,"coordinates":46},[47,48],3.88523,45.04366,{"lat":48,"lon":47},{"facility":25,"status":27,"city":51,"state":27,"zip":52,"country":33,"countryCode":34,"cosmosGeoPoint":53,"geoPoint":57,"contacts":27},"Saint-Priest-en-Jarez","42271",{"type":36,"coordinates":54},[55,56],4.37678,45.4739,{"lat":56,"lon":55},{"type":59,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR",[61],{"name":62,"class":6},"Institut de Cancérologie de la Loire","100310149","phase-2-clinical-trial-assessing-the-efficacy-of-capsaicin-patch-qutenza-in-cancer-patients-with-neuropathic-pain-100310149",false,"NCT03317613","Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain","CAPSONCO","Inclusion Criteria:\n\n* Patient with at least 18 years old;\n* Patient presenting neuropathic pain secondary to an anti-cancerous treatment;\n* Patient presenting a DN4 (Neuropathic Pain in Four Questions) score superior or equal to 4 out of 10\n* Patient presenting a skin without lesion at the painful area\n* Informed consent form signed;\n* Patient affiliated to a social security scheme.\n\nExclusion Criteria:\n\n* Hypersensitivity known to capsaicin;\n* Instable or uncontrolled hypertension;\n* Painful area localised next to eyes;\n* Pregnant or breastfeeding woman;\n* Protected people.","ALL","18 Years",{"count":73,"type":74},84,"ACTUAL","INTERVENTIONAL",[77],"PHASE2","In the oncology area, neuropathic pains are relatively frequent and can be induced by surgery, radiotherapy, or chemotherapy. In usual practice, some units are using qutenza in order to reduce neuropathic pain even though using of this patch for a population of cancer patients has never been demonstrated so far in a prospective study. The present prospective study proposes to evaluate the qutenza efficacy in peripheric neuropathic pain in cancer patients.",[80],"Neuropathic Pain",[80,17,9,82],"Cancer patient","COMPLETED","2022-02-07",{"date":86,"type":74},"2022-02-08",{"date":88,"type":74},"2017-11-09",{"date":90,"type":74},"2021-12-20",{"name":5,"class":6},3]